Table 1.

Biochemical markers of liver fibrosis and inflammation according to HLSC strains and HLSC transplantation scheme

	AST			ALT			APRI
	Baseline	Post 14w CCl4		Baseline	Post 14w CCl4		Baseline	Post 14w CCl4
Control	341.50	117.17		188.50	49.17*		0.66	0.48
HLSC7	573.50	93.00*		742.33	65.67*		1.06	0.24*
HLSC15	411	139*		437	85*		0.76	0.25*
HLSC26	538	105*		629	56*		0.98	0.25*
Control	341.50	117.17		188.50	49.17*		0.66	0.48
HLSCx	573.50	93.00*		742.33	65.67*		1.06	0.24*
HLSC2x	436.00	92.40		465.80	49.60		0.93	0.28
HLSCxx	262.40	120.00		249.40	54.40*		0.50	0.18

APRI (AST to platelet ratio index)=(AST/upper limit of normal for AST)×100/platelet count (×10⁹/l), *p<0.05.

HLSCx: single dose, single transplant; HLSC2x: double dose, single transplant; HLSCxx: single dose, tandem transplants.